Qure.ai Powers India’s First AI-Led Incidental Pulmonary Nodule Clinic at Thangam Cancer Centre

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led Incidental Pulmonary Nodule (IPN) Detection Clinic at Thangam Cancer Centre in Namakkal, Tamil Nadu.
This initiative is part of Project BreatheEZ, a broader strategic collaboration between Johnson & Johnson MedTech’s Surgery Division and Qure.ai, designed to establish AI-powered IPN Clinics across leading hospitals in India. 
The Thangam Cancer Centre IPN Clinic is India’s first dedicated Incidental Pulmonary Nodule (IPN) clinic designed to systematically detect and track lung nodules using Qure.ai’s FDA-cleared qXR solution as part of an integrated screening and care pathway. 
Speaking about the launch, Dr. Saravana Rajamanickam MS, MCh, Director, Thoracic Surgical Oncology,  Thangam Cancer Centre and Research Institute , Thangam Cancer Centre, said, " With the launch of this AI-powered clinic, we are not only enhancing our ability to detect lung cancer early but also redefining cancer care for millions in India.''
Prashant Warier, CEO and Co-Founder, Qure.ai, said, "At Qure.ai, we are committed to bridging critical healthcare gaps with AI. The partnership with Thangam Cancer Centre to turn routine chest X-rays into early warning tools is a powerful example of the potential of our AI solutions.''